Trader consensus reflects a 75% market-implied probability for the CDC issuing at least one Level 3 Travel Health Notice ("Avoid Nonessential Travel") by December 31, 2026, driven by recent escalations to Level 2 notices within the past month for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte, Suriname, Bolivia, and Seychelles. These updates from CDC surveillance underscore rising outbreak risks amid global polio circulation (Level 2, March 9) and a U.S. measles epidemic with 1,748 confirmed cases as of April 16—94% outbreak-associated across 19 new clusters—far exceeding historical baselines. Ongoing H5N1 avian influenza monitoring, with 71 U.S. human cases since 2024 but no recent transmission, adds uncertainty; weekly CDC FluView and international reports could prompt further upgrades before year-end resolution.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেডCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$112,110 Vol.
$112,110 Vol.
Dec 31, 2026
$112,110 Vol.
$112,110 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus reflects a 75% market-implied probability for the CDC issuing at least one Level 3 Travel Health Notice ("Avoid Nonessential Travel") by December 31, 2026, driven by recent escalations to Level 2 notices within the past month for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte, Suriname, Bolivia, and Seychelles. These updates from CDC surveillance underscore rising outbreak risks amid global polio circulation (Level 2, March 9) and a U.S. measles epidemic with 1,748 confirmed cases as of April 16—94% outbreak-associated across 19 new clusters—far exceeding historical baselines. Ongoing H5N1 avian influenza monitoring, with 71 U.S. human cases since 2024 but no recent transmission, adds uncertainty; weekly CDC FluView and international reports could prompt further upgrades before year-end resolution.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
মার্কেট ওপেন হয়েছে: Jan 19, 2026, 3:15 PM ET
ভলিউম
$112,110শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus reflects a 75% market-implied probability for the CDC issuing at least one Level 3 Travel Health Notice ("Avoid Nonessential Travel") by December 31, 2026, driven by recent escalations to Level 2 notices within the past month for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte, Suriname, Bolivia, and Seychelles. These updates from CDC surveillance underscore rising outbreak risks amid global polio circulation (Level 2, March 9) and a U.S. measles epidemic with 1,748 confirmed cases as of April 16—94% outbreak-associated across 19 new clusters—far exceeding historical baselines. Ongoing H5N1 avian influenza monitoring, with 71 U.S. human cases since 2024 but no recent transmission, adds uncertainty; weekly CDC FluView and international reports could prompt further upgrades before year-end resolution.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ভলিউম
$112,110শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus reflects a 75% market-implied probability for the CDC issuing at least one Level 3 Travel Health Notice ("Avoid Nonessential Travel") by December 31, 2026, driven by recent escalations to Level 2 notices within the past month for meningococcal disease in the Democratic Republic of the Congo (March 24), yellow fever in Venezuela (March 16), and chikungunya in Mayotte, Suriname, Bolivia, and Seychelles. These updates from CDC surveillance underscore rising outbreak risks amid global polio circulation (Level 2, March 9) and a U.S. measles epidemic with 1,748 confirmed cases as of April 16—94% outbreak-associated across 19 new clusters—far exceeding historical baselines. Ongoing H5N1 avian influenza monitoring, with 71 U.S. human cases since 2024 but no recent transmission, adds uncertainty; weekly CDC FluView and international reports could prompt further upgrades before year-end resolution.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেড
বাহ্যিক লিংক থেকে সাবধান।
বাহ্যিক লিংক থেকে সাবধান।
সচরাচর জিজ্ঞাসা